Ignite Creation Date:
2024-05-05 @ 12:08 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00252564
Status:
COMPLETED
Last Update Posted:
2019-02-15
First Post:
2005-11-09
Brief Title:
Cetuximab Bevacizumab 5FULeucovorin vs Oxaliplatin Bevacizumab 5FULeucovorin in Metastatic Colorectal Cancer
Sponsor:
US Oncology Research
Organization:
US Oncology Research
Organization Data
Organization:
US Oncology Research
Class:
INDUSTRY
Study ID:
05-041
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
US Oncology Research
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Bristol-Myers Squibb | INDUSTRY |
| Memorial Sloan Kettering Cancer Center | OTHER |
| Prologue Research International | INDUSTRY |